Showing 1 - 6 results of 6 for search 'Ian N. Hampson', query time: 0.03s Refine Results
  1. 1
    Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology

    Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology by Ian N. Hampson

    Published 2022-04-01
    Get full text
    Article
  2. 2
    Update on Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology

    Update on Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology by Ian N. Hampson, Anthony W. Oliver

    Published 2024-08-01
    Get full text
    Article
  3. 3
    Potential Effects of Human Papillomavirus Type Substitution, Superinfection Exclusion and Latency on the Efficacy of the Current L1 Prophylactic Vaccines

    Potential Effects of Human Papillomavirus Type Substitution, Superinfection Exclusion and Latency on the Efficacy of the Current L1 Prophylactic Vaccines by Ian N. Hampson, Anthony W. Oliver, Lynne Hampson

    Published 2020-12-01
    Get full text
    Article
  4. 4
    No biological evidence of XMRV infection in cervical smears from HIV/ HPV positive and negative Kenyan women.

    No biological evidence of XMRV infection in cervical smears from HIV/ HPV positive and negative Kenyan women. by Xiaotong He, Thomas D J Walker, Innocent O Maranga, Anthony W Oliver, Lynne Hampson, Ian N Hampson

    Published 2012-01-01
    Get full text
    Article
  5. 5
    Analysis of factors contributing to the low survival of cervical cancer patients undergoing radiotherapy in Kenya.

    Analysis of factors contributing to the low survival of cervical cancer patients undergoing radiotherapy in Kenya. by Innocent O Maranga, Lynne Hampson, Anthony W Oliver, Anas Gamal, Peter Gichangi, Anselmy Opiyo, Catharine M Holland, Ian N Hampson

    Published 2013-01-01
    Get full text
    Article
  6. 6
    A Single-Arm, Proof-Of-Concept Trial of Lopimune (Lopinavir/Ritonavir) as a Treatment for HPV-Related Pre-Invasive Cervical Disease.

    A Single-Arm, Proof-Of-Concept Trial of Lopimune (Lopinavir/Ritonavir) as a Treatment for HPV-Related Pre-Invasive Cervical Disease. by Lynne Hampson, Innocent O Maranga, Millicent S Masinde, Anthony W Oliver, Gavin Batman, Xiaotong He, Minaxi Desai, Parmenas M Okemwa, Helen Stringfellow, Pierre Martin-Hirsch, Alex M Mwaniki, Peter Gichangi, Ian N Hampson

    Published 2016-01-01
    Get full text
    Article

Search Tools: